Skip to main content
. 2017 Dec 8;11:130. doi: 10.1186/s13065-017-0357-2

Table 11.

Antihyperglycemic activity profile of title compounds thiazolidine-2,4-dione derivatives

Compounds Antihyperglycemic activity, SLM PPARc
10 nmol 1000 nmol
28 − 22.1 9 9
29 − 22.2 7 8
30 − 15.8
31 + 9.00
32 − 26.7 10 12
33 − 12.3 9 11
34 − 12.7 8 10
35 − 4.1
36 − 26.8
Rosiglitazone 11.6 92 248
Metformin 34.1

PPAR c proxisome proliferator activated receptor